Delivery Order SPE2DR25D3103-SPE2DR26F0A7F
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,732.94 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 20, 2026, with an ultimate completion date of January 21, 2026. This firm fixed-price, non-set-aside contract was performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite...
- The Defense Logistics Agency awarded a $27,013.23 delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 20, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $11,937.78 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 20, 2026, with an ultimate completion date of January 21, 2026. This is a firm fixed-price, non-set-aside contract performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $8,048.54 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on January 7, 2026, with an ultimate completion date of January 8, 2026. The order carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $4,743.38 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 14, 2026, with completion scheduled for January 15, 2026. This firm fixed-price, non-set-aside contract is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $12,570.76 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 15, 2026, with an ultimate completion date of January 16, 2026. This firm fixed-price, non-set-aside contract will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $105,814.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) with an ultimate completion date of January 23, 2026. This contract was awarded on a non-set-aside, competitive basis to the Conshohocken, Pennsylvania-based pharmaceutical distributor, a subsidiary of parent company Cencora, Inc. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $43,104.56 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) on January 29, 2026. This firm fixed-price delivery order, which carries a completion deadline of January 30, 2026, was competitively awarded with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and distribution hub....
- The Defense Logistics Agency awarded a delivery order valued at $6,192.03 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 23, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,078.93 on January 20, 2026, to supply Jardiance 25 mg tablets (90-count) to the Defense Logistics Agency with an ultimate completion date of January 21, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. This delivery order is issued under...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F0A7FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,346.46 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 29, 2026, with an ultimate completion date of January 30, 2026. This firm fixed-price, non-set-aside contract was performed at the awardee's location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 single-award contract vehicle running through December 31, 2031, which serves as the primary procurement mechanism for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in supplying prescription medications, medical devices, and healthcare commodities across multiple therapeutic domains to the Department of Defense and other federal agencies. The Jardiance order fulfills medical supply needs within the military healthcare system, with the parent company Cencora, Inc. demonstrating substantial capability in managing large-scale government pharmaceutical contracts through its competitive, open-competition procurement approach and extensive portfolio of approved medical products spanning oncology, diabetes management, and specialized treatments required by military treatment facilities and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 1/28/26 |